Abstract |
Genetically transferred resistance to the antischistosomal drug hycanthone has been observed in several strains of Schistosoma mansoni: 1) in the progeny of worms to whose hosts hycanthone had been administered 54 to 70 days after exposure to cercariae (Type I); 2) in the progeny of worms to whose hosts hycanthone had been administered when the worms were still in an immature stage (27 to 29 days after percutaneous cercarial exposure) (Type II); and 3) in the progeny of worms from hosts that had been infected with cercariae of one sex followed by infection with the opposite sex 2 to 58 weeks later (Type III). In types I and II, drug resistance was transferred maternally. Hycanthone-resistant schistosomes were cross-resistant to antischistosomal drugs structurally related to hycanthone, such as oxamniquine and two chloro- indazole analogs of hycanthone, but not to niridazole and to another nitroheterocyclic compound.
|
Authors | W B Jansma, S H Rogers, C L Liu, E Bueding |
Journal | The American journal of tropical medicine and hygiene
(Am J Trop Med Hyg)
Vol. 26
Issue 5 Pt 1
Pg. 926-36
(Sep 1977)
ISSN: 0002-9637 [Print] United States |
PMID | 907054
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Thioxanthenes
- Oxamniquine
- Hycanthone
- Ethidium
- Quinacrine
- Niridazole
|
Topics |
- Animals
- Drug Resistance
- Ethidium
(pharmacology)
- Female
- Genes
- Hybridization, Genetic
- Hycanthone
(analogs & derivatives, pharmacology)
- Male
- Mice
- Niridazole
(pharmacology)
- Oxamniquine
(pharmacology)
- Quinacrine
(pharmacology)
- Schistosoma mansoni
(drug effects, growth & development)
- Thioxanthenes
(pharmacology)
- Time Factors
|